A stepped-care approach to symptomatic endometriosis management: a participatory research initiative
article
OA: bronze
CC0
⤵ 23 in-corpus citations
AI-generated summary
This participatory research initiative developed and evaluated a stepped-care approach to managing symptomatic endometriosis, involving patients in the process.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo assess the proportion of patients with symptomatic endometriosis satisfied with their medical treatment 12 months after enrollment in a stepped-care management protocol.DesignProspective, single-arm, self-controlled study.SettingAcademic department.Patient(s)A cohort of 157 consecutive patients referred or self-referred to our center for symptomatic endometriosis.Interventions(s)Systematic detailed information process on medical and surgical treatment followed by a shared decision to start a stepped-care protocol including three subsequent medical therapy steps (oral contraception [OC]; 2.5 mg/d norethindrone acetate [NETA]; 2 mg/d dienogest [DNG]) and a fourth surgical step. Stepping up was triggered by drug inefficacy/intolerance.Main outcome measure(s)Satisfaction with treatment was assessed according to a five-category scale (very satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied, very dissatisfied). Variations were measured in pain symptoms with the use of a 0-10-point numeric rating scale (NRS), in quality of life with the use of the Short Form 12 questionnaire (SF-12), and in sexual functioning with the use of the Female Sexual Function Index (FSFI).Result(s)At the end of the 12-month study period, 106 women were still using OC, 23 were using NETA, three were using DNG, and four had undergone surgery. Twenty-one participants (13%) dropped out from the study. In intention-to-treat analysis, excluding five drop-outs for pregnancy desire, the overall satisfaction rate with the stepped-care protocol was 62% (95/152; 95% CI 55%-70%). By 12-month follow-up, significant improvements were observed in all pain symptom scores and in SF-12 physical and mental component summary scores, whereas FSFI scores did not vary substantially.Conclusion(s)Most women with endometriosis-associated pelvic pain who chose a stepped-care approach were satisfied with OC and a low-cost progestin for the treatment of their symptoms. The need to step up to an expensive progestin or surgery was marginal.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (95)
- A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex
- Asymptomatic adenomyosis and embryo implantation in IVF cycles via openalex
- A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis via openalex
- Can we decrease breakthrough bleeding in patients with endometriosis on norethindrone acetate? via openalex
- Clinical diagnosis of endometriosis and optimal medical therapy via openalex
- Complications after surgery for deeply infiltrating pelvic endometriosis via openalex
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex
- Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis via openalex
- Diagnosis and management of endometriosis: summary of NICE guidance via openalex
- Diagnostic accuracy and potential limitations of transvaginal sonography for bladder endometriosis via openalex
- Diagnostic accuracy of transvaginal ultrasound for non‐invasive diagnosis of bowel endometriosis: systematic review and meta‐analysis via openalex
- Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
- Effect of norethindrone acetate in the treatment of symptomatic endometriosis. via openalex
- Endometriomas: their ultrasound characteristics via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis: Diagnosis and Management via openalex
- Estrogen-progestins and progestins for the management of endometriosis via openalex
- Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial via openalex
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy via openalex
- Management of endometriomas via openalex
- Management of Endometriomas via openalex
- Medical management of recurrent endometrioma with long-term norethindrone acetate via openalex
- Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study via openalex
- Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study via openalex
- Practice Bulletin No. 114: Management of Endometriosis via openalex
- Pregnancy outcome in women with peritoneal, ovarian and rectovaginal endometriosis: a retrospective cohort study via openalex
- Preoperative work-up for patients with deeply infiltrating endometriosis: transvaginal ultrasonography must definitely be the first-line imaging examination via openalex
- Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis via openalex
- Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills via openalex
- Progestogens for endometriosis: forward to the past via openalex
- Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal via openalex
- Reevaluating response and failure of medical treatment of endometriosis: a systematic review via openalex
- Reproductive performance in infertile women with rectovaginal endometriosis: Is surgery worthwhile? via openalex
- Should we also work on an international informed consent for endometriosis surgery? via openalex
- Surgery for Deep Endometriosis: A Pathogenesis-Oriented Approach via openalex
- Surgery versus hormonal therapy for deep endometriosis: is it a choice of the physician? via openalex
- Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications via openalex
- Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life via openalex
- The Impact of Excision of Ovarian Endometrioma on Ovarian Reserve: A Systematic Review and Meta-Analysis via openalex
- The Patient-Centeredness of Endometriosis Care and Targets for Improvement: A Systematic Review via openalex
- Top ten endometriosis research priorities in the UK and Ireland via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
- Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex
- Treatment of symptomatic rectovaginal endometriosis with an estrogen–progestogen combination versus low-dose norethindrone acetate via openalex
- Use of Norethindrone Acetate Alone for Postoperative Suppression of Endometriosis Symptoms via openalex
- Validation study of nonsurgical diagnosis of endometriosis via openalex
- 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis via openalex
- “We Can Work It Out:” The Hundred Years' War between Experts of Surgical and Medical Treatment for Symptomatic Deep Endometriosis via openalex
- W2172151487 via openalex
- W1998207473 via openalex
- W2275737843 via openalex
- W2378098209 via openalex
- W2401134385 via openalex
- W2514175137 via openalex
- W1992974620 via openalex
- W1966091296 via openalex
- W2587440352 via openalex
- W2599076725 via openalex
- W2604185978 via openalex
- W1585019003 via openalex
- W1574745824 via openalex
- W360607004 via openalex
- W99140794 via openalex
- W4292806894 via openalex
- W6601145584 via openalex
- W6607311167 via openalex
- W6673264567 via openalex
- W6683694485 via openalex
- W2045458073 via openalex
- W2050302634 via openalex
- W2037377025 via openalex
- W2037266595 via openalex
- W2084007114 via openalex
- W2091024615 via openalex
- W2021553800 via openalex
- W2101417341 via openalex
- W2112997260 via openalex
- W2120385927 via openalex
- W2126339803 via openalex
- W2129163850 via openalex
- W2130203785 via openalex
- W2132577372 via openalex
- W2135413686 via openalex
- W2138154261 via openalex
- W2144685382 via openalex
- W2146098026 via openalex
- W2147117726 via openalex
- W2014677557 via openalex
- W2157853773 via openalex
- W2160662478 via openalex
- W2160679825 via openalex
- W2163315477 via openalex
- W2163605459 via openalex
- W2167077456 via openalex
Cited by (23)
- IMPACTO DA ENDOMETRIOSE NA QUALIDADE DE VIDA DAS PACIENTES ACOMETIDAS: REVISÃO SISTEMATIZADA. 2025
- Evaluation and Treatment of Chronic Pelvic Pain 2025
- Using systems biology and drug repositioning approaches to discover FDA-approved drugs candidates for endometriosis treatment 2025
- Advances in the diagnosis and management of endometriosis: A comprehensive review 2025
- Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3) 2024
- Advances in the Diagnosis and Management of Endometriosis: A Comprehensive Review 2024
- Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not? 2023
- Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions 2023
- Nuevas perspectivas en el abordaje farmacológico del dolor en mujeres con endometriosis. 2023
- Developing a set of patient-centered outcomes for routine use in endometriosis: An international Delphi study 2023
- Dismenorreas en la adolescente 2022
- Associação entre os sintomas e a topografia das lesões da endometriose pélvica 2022
- Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
- Endometriosis - Recent Advances, New Perspectives and Treatments 2021
- Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review 2021
- Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what’s the best choice? 2021
- Patient-Reported Outcome Measures in Endometriosis 2021
- Diagnosing endometriosis before laparoscopy: radiologic tools to evaluate the disease 2020
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Treatment patterns of women with endometriosis in Canada 2020
- When to Do Surgery and When Not to Do Surgery for Endometriosis: A Systematic Review and Meta-analysis 2019
- Letter to the Editor: “Progesterone Receptor Status Predicts Response to Progestin Therapy in Endometriosis” 2019
- Elagolix for endometriosis: all that glitters is not gold 2018
Source provenance
- europepmc
- last seen: 2026-07-28T06:14:09.330459+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:19:43.094626+00:00
License: CC0
· commercial use OK